Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$6.76M Buy
49,970
+3,766
+8% +$383K 0.02% 703
2020
Q3
$3.84M Buy
46,204
+14
+0% +$1.12K 0.01% 824
2020
Q2
$3.79M Buy
46,190
+22,063
+91% +$1.49M 0.01% 831
2020
Q1
$1.24M Buy
24,127
+18,336
+317% +$956K 0.01% 1212
2019
Q4
$241K Buy
+5,791
New +$214K ﹤0.01% 2138
2019
Q3
Sell
-2,729
Closed -$95K 2781
2019
Q2
$95K Buy
+2,729
New +$80.4K ﹤0.01% 2396

Other funds holding ZLAB

Aperio Group's ZLAB Position: Q4 2020 in Review

Aperio Group increased its Zai Lab (ZLAB) stake by 8.2% in Q4 2020, buying an estimated $383K and bringing the position to 49,970 shares worth $6.76M. The position accounts for 0.02% of the portfolio, ranked #703.

Aperio Group first reported a position in ZLAB in Q2 2019 and has held it in 6 quarters since. 191 funds tracked by Wall St. Rank hold ZLAB as of Q4 2020.

  • Aperio Group held 49,970 shares of Zai Lab worth $6.76M as of Q4 2020.
  • Aperio Group bought 3,766 Zai Lab shares in Q4 2020, an estimated $383K.
  • Zai Lab made up 0.02% of Aperio Group's portfolio in Q4 2020, its #703 holding.
  • Aperio Group first reported a position in Zai Lab in Q2 2019 and has held it in 6 quarters since.
  • 191 funds tracked by Wall St. Rank held Zai Lab as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.